These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
498 related items for PubMed ID: 15194579
21. [Molecular genetic, laboratory and clinical study of serum amyloid P]. Biró J, Balogh Z, Szongoth M, Megyeri A, Bély M, Falus A. Orv Hetil; 1992 Apr 05; 133(14):841-5. PubMed ID: 1522987 [Abstract] [Full Text] [Related]
22. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis. Shen C, Sun XG, Liu N, Mu Y, Hong CC, Wei W, Zheng F. Mol Med Rep; 2015 Feb 05; 11(2):1528-34. PubMed ID: 25352049 [Abstract] [Full Text] [Related]
23. Interleukin-1 and the acute-phase response: induction of mouse liver serum amyloid A mRNA by murine recombinant interleukin-1. Weinstein JA, Taylor JM. J Trauma; 1987 Nov 05; 27(11):1227-32. PubMed ID: 3119866 [Abstract] [Full Text] [Related]
24. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE, Sütsch G, Roffi M, Neidhart M, Eberli FR, Tanner FC, Gobbi S, von Eckardstein A, Lüscher TF. Circulation; 2005 Mar 22; 111(11):1355-61. PubMed ID: 15753219 [Abstract] [Full Text] [Related]
25. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics. Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT. J Eur Acad Dermatol Venereol; 2009 Apr 22; 23(4):433-7. PubMed ID: 19335730 [Abstract] [Full Text] [Related]
27. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E. J Autoimmun; 2008 Dec 22; 31(4):372-6. PubMed ID: 18926664 [Abstract] [Full Text] [Related]
28. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. de Beer FC, Baltz ML, Munn EA, Feinstein A, Taylor J, Bruton C, Clamp JR, Pepys MB. Immunology; 1982 Jan 22; 45(1):55-70. PubMed ID: 7056568 [Abstract] [Full Text] [Related]
29. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins. Sjöwall C, Wetterö J. Clin Chim Acta; 2007 Mar 22; 378(1-2):13-23. PubMed ID: 17239838 [Abstract] [Full Text] [Related]
30. Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant? Ames PR, Alves J, Pap AF, Ramos P, Khamashta MA, Hughes GR. J Rheumatol; 2000 May 22; 27(5):1190-5. PubMed ID: 10813286 [Abstract] [Full Text] [Related]
31. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. Eur Heart J; 1999 Jul 22; 20(13):954-9. PubMed ID: 10361047 [Abstract] [Full Text] [Related]
33. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination? Pezzilli R, Gabbrielli A, Labate AM, D'Alessio P, Barakat B, Costamagna G, Dibenedetti F, Massa M, Merlini G, d'Eril GM. Hepatogastroenterology; 2003 Jul 22; 50(51):851-5. PubMed ID: 12828103 [Abstract] [Full Text] [Related]
34. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Morgan PE, Sturgess AD, Davies MJ. Arthritis Rheum; 2005 Jul 22; 52(7):2069-79. PubMed ID: 15986354 [Abstract] [Full Text] [Related]
36. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension. Tsioufis C, Stougiannos P, Kakkavas A, Toutouza M, Mariolis A, Vlasseros I, Stefanadis C, Kallikazaros I. Am J Cardiol; 2005 Jul 15; 96(2):252-6. PubMed ID: 16018852 [Abstract] [Full Text] [Related]
37. Elevation of serum CXCL13 in SLE as well as in sepsis. Schiffer L, Kielstein JT, Haubitz M, Lührs H, Witte T, Haller H, Kümpers P, Schiffer M. Lupus; 2011 Apr 15; 20(5):507-11. PubMed ID: 21078761 [Abstract] [Full Text] [Related]
38. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study. Eilertsen GØ, Van Ghelue M, Strand H, Nossent JC. Rheumatology (Oxford); 2011 Dec 15; 50(12):2197-205. PubMed ID: 21984763 [Abstract] [Full Text] [Related]
39. Targeted protein quantitation and profiling using PVDF affinity probe and MALDI-TOF MS. Chen SH, Liao HK, Chang CY, Juo CG, Chen JH, Chan SI, Chen YJ. Proteomics; 2007 Sep 15; 7(17):3038-50. PubMed ID: 17676666 [Abstract] [Full Text] [Related]
40. Establishment of an in-house ELISA and the reference range for serum amyloid A (SAA): complementarity between SAA and C-reactive protein as markers of inflammation. Wu TL, I Chen Tsai, Chang PY, Tsao KC, Sun CF, Wu LL, Wu JT. Clin Chim Acta; 2007 Feb 15; 376(1-2):72-6. PubMed ID: 16916504 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]